Where does Clarity Medical Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Clarity Medical Systems, Inc. ranks #20,936 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Clarity Medical Systems, Inc. hold?

Clarity Medical Systems, Inc. holds 13 US utility patents granted between 2015 and 2017, spanning 4 technology areas.

What is Clarity Medical Systems, Inc.'s Innovation Score?

Clarity Medical Systems, Inc. has an Innovation Score of 24.5 out of 100 (15th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Clarity Medical Systems, Inc. focus on?

Clarity Medical Systems, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents, ranking #1,451 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Clarity Medical Systems, Inc.'s patent grant rate increasing or decreasing?

Clarity Medical Systems, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Clarity Medical Systems, Inc.'s patents?

Clarity Medical Systems, Inc.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Clarity Medical Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Clarity Medical Systems, Inc.

USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clarity ranks #20,936 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.

#20,936
of 49,997 US assignees by volume: 15th percentile
by Innovation Score (24.5/100): 13.8
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20936 · US Corporation #20,936 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,936/49,997
PHOTO-FINISH Chromalox
CPC-NARROW A61B · 4 areas
INNOV-THIN 24.5/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chromalox, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clarity’s 24.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (37%) Velocity 0.0 pts (0%) Breadth 7.1 pts (29%) Claim depth 8.3 pts (34%)

Qualcomm Incorporated · highest

85
Clarity Medical… · this assignee

25
3D Lighting… · lowest

7

What this shows Clarity's Innovation Score is 24.5/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clarity?

Each dot is one of Clarity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clarity’s own 13.8 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clarity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clarity's grants concentrate

Clarity Medical Systems, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 92.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (7 grants) versus a trough of 3 in 2016. By volume, Clarity sits between Chromalox, Inc. and CollPlant Ltd..

Chromalox

13
Circuit Seed

13
Circuit Therapeut…

13
Cixi City Liyuan…

13
Cleland Sales

13
Cleveland Reclaim…

13
Cogito

13
Collplant

13
Clarity Medical S… ◀

13

What this shows Clarity holds 13 patents at rank #20,953, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Clarity

By rank, the assignees closest to #20,953 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Clarity's primary technology class.

Clarity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 15th percentile higher than 15% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Clarity Medical Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	53.8%
2016	3	23.1%
2017	3	23.1%

Which technologies does Clarity Medical Systems, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 10

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

G02B - Optical Elements, Systems OR Apparatus 3

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Clarity Medical Systems, Inc.'s patent record in context - here's where to go next.

Clarity Medical Systems, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 92.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #20,936 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Clarity Medical Systems, Inc. against Chromalox, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.